Climatotherapy At The Dead Sea For Atopic Dermatitis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01307150
Recruitment Status : Unknown
Verified July 2009 by Hadassah Medical Organization.
Recruitment status was:  Not yet recruiting
First Posted : March 2, 2011
Last Update Posted : March 2, 2011
Information provided by:
Hadassah Medical Organization

Brief Summary:
The purpose of this study is to evaluate the improvement in severity of Atopic Dermatitis and quality of life after 4 weeks of treatment in the Dead Sea.

Condition or disease
Atopic Dermatitis

Detailed Description:

28 days treatment period, sun exposure and possibly Dead Sea baths after an exact given plan, discontinuation of all local Cortisone preparations, unlimited use of maintenance drags, doctor visit twice a week, continuous checks by the nurse.

Determination of the SCORAD index by the same doctor on arrival and departure. Before and after the treatment, the patient will answer written questionnaires regarding quality of life.

Study Type : Observational
Estimated Enrollment : 50 participants
Observational Model: Case-Crossover
Time Perspective: Prospective
Official Title: Evaluation of the Efficacy of Dead Sea Climatotherapy on Atopic Dermatitis Patients.
Study Start Date : June 2009
Estimated Primary Completion Date : November 2009
Estimated Study Completion Date : December 2009

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Eczema

Before and after treatment
SCORAD of each patient before and after treatment.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Atopic Dermatitis patient.

Inclusion Criteria:

  • Minimum age of 18 years old

Exclusion Criteria:

  • Skin type - I
  • Psoriasis patient in addition to Atopic Dermatitis
  • Pregnancy
  • Past malignancy
  • Less then 2 weeks of treatment

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01307150

Contact: Arik Tzukert, DMD +972-(0)2-6776095
Contact: Hadas Lemberg, PhD +972-(0)2-6777572

DMZ Clinic Not yet recruiting
Jerusalem, Israel
Contact: Marco Harari, Dr.    +972-(0)8-6689200   
Sponsors and Collaborators
Hadassah Medical Organization
Study Chair: Arie Ingber, MD. Hadassa Medical Organization IRB

Publications of Results:
Responsible Party: Hasassah Medical Organization IRB, Israel Ministry of Health Identifier: NCT01307150     History of Changes
Other Study ID Numbers: SK09409-HMO-CTIL
First Posted: March 2, 2011    Key Record Dates
Last Update Posted: March 2, 2011
Last Verified: July 2009

Keywords provided by Hadassah Medical Organization:
Atopic Dermatitis
Dead Sea

Additional relevant MeSH terms:
Dermatitis, Atopic
Skin Diseases
Skin Diseases, Genetic
Genetic Diseases, Inborn
Skin Diseases, Eczematous
Hypersensitivity, Immediate
Immune System Diseases